Estimated read time: Less than a minute
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
(AP) - ACCELERATED APPROVAL: Government scientists on Tuesday recommended speedy approval for a Roche breast cancer drug that could become the first pharmaceutical product approved for use before surgery.
NEW OPTION: Preliminary results submitted by Roche showed that women who received the drug Perjeta were more likely to be cancer-free than women receiving older drug combinations.
COMMITTEE OPINION: On Thursday, the FDA will ask an outside panel of cancer specialists whether Perjeta's benefits outweigh its risks for treating early-stage breast cancer. The vote is non-blinding but factors into the FDA's decision.
(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
